Free Trial

Mizuho Securities USA LLC Acquires Shares of 200,000 Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Oaktree Acquisition Corp. III Life Sciences logo with Financial Services background

Key Points

  • Mizuho Securities USA LLC has acquired a new stake in Oaktree Acquisition Corp. III Life Sciences, purchasing 200,000 shares valued at approximately $2,020,000.
  • Oaktree Acquisition Corp. III Life Sciences, a blank check company founded in 1995, aims to engage in mergers or acquisitions with businesses.
  • At the close of the recent reporting period, Mizuho Securities owned about 0.89% of Oaktree Acquisition Corp. III Life Sciences.
  • Looking to export and analyze Oaktree Acquisition Corp. III Life Sciences data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Mizuho Securities USA LLC purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 200,000 shares of the company's stock, valued at approximately $2,020,000. Mizuho Securities USA LLC owned approximately 0.89% of Oaktree Acquisition Corp. III Life Sciences as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. AQR Arbitrage LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $19,743,000. Toronto Dominion Bank bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $14,355,000. Shaolin Capital Management LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $5,478,000. Two Sigma Investments LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $4,358,000. Finally, Lighthouse Investment Partners LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at $3,039,000.

Oaktree Acquisition Corp. III Life Sciences Stock Down 1.4%

NASDAQ:OACC traded down $0.15 during midday trading on Friday, reaching $10.30. 125,198 shares of the stock traded hands, compared to its average volume of 17,942. The business has a fifty day moving average of $10.48. Oaktree Acquisition Corp. III Life Sciences has a 12 month low of $9.95 and a 12 month high of $10.85.

Oaktree Acquisition Corp. III Life Sciences Company Profile

(Free Report)

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

See Also

Institutional Ownership by Quarter for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Should You Invest $1,000 in Oaktree Acquisition Corp. III Life Sciences Right Now?

Before you consider Oaktree Acquisition Corp. III Life Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oaktree Acquisition Corp. III Life Sciences wasn't on the list.

While Oaktree Acquisition Corp. III Life Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines